Search
×
FR

Placeholder headline

This is just a placeholder headline

API TR 5C3: Calculating Performance Properties of Pipe Used as Casing or Tubing

$

422

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 671: Special Purpose Couplings for Petroleum, Chemical and Gas Industry Services

$

502

BUY NOW

Placeholder headline

This is just a placeholder headline

Technical Report API TBD-10: Chapter 10 Surface and Interfacial Tension

$

176

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 671: Special Purpose Couplings for Petroleum, Chemical and Gas Industry Services: Errata 2

$

0

BUY NOW

Placeholder headline

This is just a placeholder headline

MSS SP-44-2026: Steel Pipeline Flanges

$

450

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 576: Inspection of Pressure-relieving Devices

$

460

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 591: Process Valve Qualification Procedure

$

226

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 576: Inspection of Pressure-relieving Devices: Addendum 1

$

0

BUY NOW

ISO 7552:2024

ISO 7552:2024 Molecular in vitro diagnostic examinations – Specifications for pre-examination processes for circulating tumour cells (CTCs) in venous whole blood – Part 1: Isolated RNA

CDN $233.00

Description

This document specifies requirements and gives recommendations on the handling, storage, CTC enrichment and isolation, RNA isolation and storage, and documentation of venous whole blood specimens intended for the examination of RNA isolated from circulating tumour cells (CTCs) during the pre-examination phase before a molecular examination is performed.

This document is applicable to molecular in vitro diagnostic examinations including laboratory-developed tests performed by medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions, and commercial organizations performing biomedical research, and regulatory authorities.

This document does not cover the isolation of cellular RNA directly from venous whole blood containing CTCs. This is covered in ISO 20186-1.

This document does not cover the isolation of specific white blood cells and subsequent isolation of cellular RNA therefrom. This document does not cover pre-analytical workflow requirements for viable CTC cryopreservation and culturing.

NOTE 1        The requirements given in this document can also be applied to other circulating rare cells (e.g. foetal cells).

NOTE 2        International, national or regional regulations or requirements can also apply to specific topics covered in this document.

Edition

1

Published Date

2024-11-04

Status

PUBLISHED

Pages

19

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document specifies requirements and gives recommendations on the handling, storage, CTC enrichment and isolation, RNA isolation and storage, and documentation of venous whole blood specimens intended for the examination of RNA isolated from circulating tumour cells (CTCs) during the pre-examination phase before a molecular examination is performed.

This document is applicable to molecular in vitro diagnostic examinations including laboratory-developed tests performed by medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions, and commercial organizations performing biomedical research, and regulatory authorities.

This document does not cover the isolation of cellular RNA directly from venous whole blood containing CTCs. This is covered in ISO 20186-1.

This document does not cover the isolation of specific white blood cells and subsequent isolation of cellular RNA therefrom. This document does not cover pre-analytical workflow requirements for viable CTC cryopreservation and culturing.

NOTE 1        The requirements given in this document can also be applied to other circulating rare cells (e.g. foetal cells).

NOTE 2        International, national or regional regulations or requirements can also apply to specific topics covered in this document.

Previous Editions

Can’t find what you are looking for?

Please contact us at: